Adriana Rossi, MD | Authors

Articles

The Evolving Treatment Landscape for TCR MM

April 14, 2021

An expert in multiple myeloma shares her perspective on the significance of recent single-agent approvals for patients with triple-class refractory multiple myeloma and highlights promising combination regimens under investigation.